Intel (INTC) CEO says quantum computing will become mainstream within three to five years
Every headline is on the live feed 20 minutes before this site.
Intel (INTC) CEO says quantum computing will become mainstream within three to five years
A sudden fire reportedly broke out in an oil field in Saudi Arabia, Ali Bk reports citing satellite imagery
Iranian Major General Rezaei says the US has accepted some of Iran's seven conditions, but Tehran considers Washington's response insufficient, adding that Iran's diplomacy has changed and will not return to the past, IRIB reports
On the Newsquawk feed at , 20 minutes before this page.
Context
Executive commentary of this kind sits in the category of long-horizon technology framing rather than financial guidance, and episodes of this sort have historically moved the equity only where the market treats the speaker's franchise as a credible read on the underlying technology. The track record that matters here is twofold: Intel's own history of roadmap commitments on process technology, where slippage has conditioned how the street discounts forward statements from the corner office, and the broader pattern of incumbents attaching themselves to nascent computing paradigms, where prior cycles have seen aggressive timelines quietly revised. A three-to-five-year mainstreaming call is on the optimistic end of the range that researchers and pure-play quantum names have typically offered, and the transmission channel, if any, runs through the quantum-exposed peer set and thematic baskets rather than through Intel's near-term earnings power, since the company has no disclosed quantum revenue line of consequence. The distinction worth drawing is between aspirational positioning and capital commitment: the former costs nothing and has tended to fade, the latter shows up in R&D disclosure, partnerships, or foundry angle commentary. The follow-ons are whether the claim is repeated with specifics on the next earnings call or investor event, and whether peers in the quantum space endorse or contradict the timeline.
Related headlines
- Micron (MU) says it plans to construct new fabrication facilities and/or ramp production at existing fabrication facilities to increase supply in to respond to a significant increase in demand for memory products2 days ago
- GlobalFoundries (GFS) unveils FDX Fusion FD-SOI platform for physical AI2 days ago
- Newsquawk Daily European Equity Opening News - 12th October 20261 hour ago
- Newsquawk Weekly US Earnings Estimates: 12-16th October 2026: Earnings season begins with big banks the highlights2 days ago
- PRE-MARKET AUSTRALIAN STOCKS NEWS: Arafura Rare Earths (ARU AT) entered into a binding offtake agreement with a global trading company to supply 850 tonnes per annum of NdPr oxide8 hours ago
- Newsquawk Weekly Economic Calendar - 12th-16th October 20262 days ago
- Google (GOOGL) is preparing to publicly roll out its new Gemini 4 model, internally known as Argon, reports Business Insider citing sources; Most recently, employees have been trying a new version of Gemini 4 internally named Carbon2 days ago
- Hunterbrook says Meta's (META) Muse growth slows as downloads fall2 days ago
- US BROKER MOVES: CBOE upgraded at Morgan Stanley; DD downgraded at JPM2 days ago
- US PRE-MARKET MOVERS: AAPL, SPCX, DAL, HUM/ALHC, LITE2 days ago
- Netflix (NFLX) restructuring to impact roughly 5% employees and could be announces as early as next week, Puck reports citing sources2 days ago
- China's CPCA says Tesla (TSLA) sold 95,366 Chinese-made vehicles in September2 days ago
- White House reportedly to let Trump beef import plan expire in November, reports Politico2 days ago
- Delta (DAL) expects operational recovery performance to "further improve" through year-end and into 2027, despite a challenging summer operating environment 2 days ago
- US EQUITY OPEN: Stocks open higher with Nasdaq leading gains2 days ago
- Delta (DAL) CEO says it was a challenging quarter due to 60% rise in fuel costs, but maintained overall profitability; prices will rise further in Q42 days ago
- Johnson & Johnson (JNJ) says 2-year ICOTYDE data in moderate-to-severe plaque psoriasis showed sustained efficacy through week 1122 days ago
- AT&T (T) offers up to USD 1,200 off iPhone duo with eligible trade-in2 days ago
- Eli Lilly (LLY) announces new exploratory data from the TOGETHER-PsO Phase 3b clinical trial evaluating the concomitant use of Taltz and Zepbound in adults with Psoriasis and Obesity2 days ago
- Delta Air Lines Inc. (DAL) Q3 2026 (USD): EPS 1.72 (exp. 1.76), Revenue 20.2bln (exp. 18.92bln). Current FY EPS 5.10-5.60 (exp. 5.43)2 days ago
The feed had this first.
Use the Platform